palmitoyl octapeptide-40 hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

palmitoyl octapeptide-40 hamilelikte güvenli mi?

No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety concern located for palmitoyl octapeptide-40; no peer-reviewed evidence of reproductive/teratogenic effects in humans or animals. Typical cosmetic peptides have low dermal bioavailability (CIR, general peptide safety literature). Sources searched: ECHA Annex VI, SCCS/CIR, PubMed, PubChem, CosIng, EWG.

palmitoyl octapeptide-40 emzirirken güvenli mi?

No data indicating reproductive or lactation toxicity or breastmilk transfer; no regulatory flags (ECHA Annex VI, SCCS/CIR). Topical peptide of this size is unlikely to reach systemic levels that would pose a breastfeeding hazard based on absence of adverse findings in available databases.

palmitoyl octapeptide-40 bebek cildi için güvenli mi?

No evidence of developmental or pediatric toxicity. Mechanistic concerns not identified. Exposure scored higher (+1) for infants because infant skin has higher permeability and surface-area-to-weight; although palmitoyl peptides are large and expected to have negligible absorption in adults, infant exposure is considered low but measurable compared with adults. No infant-specific adverse data found.

VeriMom palmitoyl octapeptide-40 nasıl puanlıyor?

VeriMom palmitoyl octapeptide-40'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.

Hamilelikte palmitoyl octapeptide-40 yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.